Divergent Tabletop Wiki

Psychopathology In Adolescents And Adults With Autism Spectrum Disorders

8 min readEdit

Autism Spectrum Disorder

Overview

Autism Spectrum Disorder (ASD) is a lifelong Neurodevelopmental condition characterized by persistent deficits in Social communication and interaction across multiple contexts, and restricted, repetitive patterns of behavior, interests, or activities. The DSM-5 recognizes three functioning levels reflecting real-world Support needs rather than previous terminology. Autism Spectrum Disorder is highly heritable (approximately 49%) and requires early recognition and correct treatment across the lifespan for optimal outcomes.

Core Diagnostic Features

Two Primary Criteria

Social communication and Interaction Deficits include difficulties with:

Restricted, Repetitive behaviors include:

  • Speech abnormalities including echolalia (immediate or delayed), repetitive vocalizations, neologisms, pronoun reversal
  • Motor stereotypies including repetitive hand movements, complex whole-body movements, unusual facial grimacing
  • Object use and rituals including nonfunctional play, object alignment, ritualized patterns
  • Restricted interests that are highly fixated and abnormal in intensity
  • Sensory sensitivities involving hyper- or hypo-reactivity to Sensory input

Critical Diagnostic principle: symptoms must appear before age 8 (though may not fully manifest until social demands exceed capacities around age 8) and must limit and impair everyday functioning to avoid overdiagnosis.

Functioning Levels

Level 1 (“Requiring Support”): Social communication difficulties and ritualistic behaviors causing some functional interference. Asperger syndrome falls into this category and represents a particularly challenging Diagnostic presentation in adolescence and adulthood.

Level 2 (“Substantial Support”): Marked deficits in verbal and Nonverbal communication with significant social impairment even with supports.

Level 3 (“Very Substantial Support”): Most severe presentation with severe deficits in communication and marked interference with functioning.

Female Autism and Camouflaging

Female Asperger syndrome Diagnosis is particularly challenging because:

  • Restricted interests often less unusual (may center on social activities like makeup)
  • Autism is “internalized” with high hypersensitivity
  • Social deficits masked by imitative coping skills

Females use “camouflage or pretending to be normal” through prolonged observation of peers, reading psychology books, and imitating fictional characters. This Camouflaging causes “exhaustion and confusion about individual’s true identity.” Girls with AS may appear socially functional to casual observers while experiencing severe internal distress, creating vulnerability to sexual abuse and exploitation.

Developmental Red Flags

By 6 months: No social smiles or warm joyful expressions, limited Eye contact By 9 months: No sharing of vocal sounds, smiles, or Nonverbal communication
By 12 months: No babbling, no gestures, no response to name By 16 months: No words By 24 months: No meaningful two-word phrases

Any loss of previously acquired speech, social skills, or babbling is concerning. Selective feeding, lack of response to name, unusual prosody, repetitive movements, or repetitive body posturing at 2-3 years are clear markers.

Psychiatric Comorbidity Overview

Lifetime psychiatric Comorbidity is “very common in adolescence and adulthood”:

Female Autistic individuals show higher risk for Anxiety, Depression, suicidal ideation, and psychiatric hospitalization than males.

Anxiety Disorder Prevalence

Up to 80% of children with ASD suffer from one or more Anxiety disorders:

  • Separation Anxiety disorder (38%)
  • Obsessive-compulsive disorder (37%)
  • Generalized Anxiety disorder (35%)
  • Social phobia (30%)

Multidisciplinary Assessment

No single test diagnoses ASD—clinical judgment using DSM-5 criteria remains primary. The multistep approach includes:

  1. International validated Diagnostic criteria
  2. Clinical information from family and individual
  3. Psychiatric and Neurological examination
  4. Test evaluation
  5. Medical Assessment
  6. Personalized treatment planning

Key Assessment Tools

Screening Tools (NOT Diagnostic):

Diagnostic Instruments:

Cognitive Assessment:

  • WAIS-IV for verbal patients
  • Raven Matrices for language difficulties
  • Leiter-R for nonverbal patients

Medical Assessment

Blood Work Should Assess

  • Glycemia, cholesterol, triglycerides
  • Vitamin/mineral status (folate, B12, iron, vitamin D)
  • Endocrine function (TSH, prolactin, cortisol)
  • Metabolic disorders when indicated

Genetic Syndromes Associated With Asd

Environmental Factors

40-50% of ASD liability variance determined by environmental factors:

  • Prenatal exposure to particulate matter, pesticides, inorganic mercury
  • Infections including cytomegalovirus and rubeola in pregnancy
  • Lyme borreliosis (Borrelia burgdorferi) increasingly recognized

Neurobiological Foundations

Brain Alterations

Schizophrenia spectrum disorder, ASD, and obsessive-compulsive spectrum disorder share distributed patterns of gray and white matter abnormalities. Two major alteration clusters identified:

Cluster 1 (more specific to schizophrenia): Anterior insula, anterior cingulate cortex, ventromedial prefrontal cortex

Cluster 2 (more specific to OCD): Occipital, temporal, and parietal alterations

Autism appears uniformly distributed across both clusters, sharing neurobiological features with both conditions.

Key Brain Regions

The Insula: Integrates external Sensory stimuli with emotions, generates conscious perception of error. Dysfunctional anterior insula connectivity plays important role in autism.

Superior Temporal Gyrus: Processes biological motion and multimodal Sensory-limbic integration. Abnormalities associated with verbal and Nonverbal communication impairments.

Thalamus: Reduced thalamic gray matter density relates to intellectual disabilities in ASD; thalamofrontal hypoconnectivity associated with ASD.

Genetic and Neurochemical Factors

Shared Genetic Alterations: SHANK3 variations, DISC1 gene, dysregulation of CYFIP1, SCN2A, NRXN1 neurexin gene, RELN

Neurochemical Imbalance:

  • Oxytocin regulating social behavior involved in both ASD and schizophrenia
  • GABA–glutamate ratio alterations central to both conditions
  • Serotonergic system alterations including hyperserotonemia, reduced 5-HT2A receptor binding

Bipolarity and Autism Overlap

Prevalence

Bidirectional Comorbidity substantially higher than chance:

  • BD prevalence in ASD children ranges from 2.3% to 10.4%
  • Higher rates in Asperger syndrome (8.6%) compared to autism (3.0%)
  • In adult samples, prevalence ranges from 6-40%
  • Up to 66% in some Asperger syndrome populations

Clinical Features

Manic episodes in adults with ASD frequently present with:

  • Irritable, unstable, dysphoric mood rather than euphoric
  • Restlessness, Anxiety, perplexity, aggression
  • Psychotic symptoms may be prominent

Critical Distinction: Distinguishing ASD-specific bizarre thinking from true psychotic symptoms is critical. Autistic peculiarities of thinking are stable, long-lasting (present since childhood) and less emotionally distressing than schizophrenia.

Depression in Asd

Often barely recognizable due to mild severity and chronic course. Core Autistic dimensions like blunt affect may simply amplify during Depression. Variations in psychomotricity and neurovegetative functioning are the best Diagnostic parameters.

Suicidality Risk

Ranges from 11-50% in ASD populations—dramatically higher than schizophrenic patients (7-10%). This represents a primary clinical challenge requiring heightened vigilance.

Adult Adhd and Adhd-Asd Comorbidity

Adult Adhd Presentation

Overt hyperactivity decreases with age, transforming into:

  • Inner restlessness, nervousness, excessive talkativeness
  • Inattention and disorganization
  • Poor sense of time and forgetfulness
  • Emotional dysregulation (poor self-regulation, volatility, irritability)

Prevalence and Overlap

28–44% of adults with ASD also meet criteria for ADHD, while 15–25% of youth with ADHD exhibit ASD traits. Large-scale genome-wide studies reveal ASD and ADHD share the same genetic susceptibility, with 50–70% overlap in contributing genetic factors.

Treatment Approaches

Multimodal treatment comprising:

Stimulants show lower effect sizes in ASD+ADHD than ADHD alone, with higher side effects including social withdrawal and mood dysregulation.

Anxiety Disorders in Asd

Clinical Phenotypes

Three primary Anxiety frameworks:

  1. Social Anxiety
  2. Anxiety with phobias or excessive worries
  3. Anxiety with obsessive-compulsive traits

Neurobiological Factors

Treatment

CBT shows 60% positive response rates with protocols including:

  1. Psycho-educational approach
  2. Cognitive restructuring
  3. Hierarchized exposure

Pharmacological: SSRIs and SNRIs first-line with proven efficacy. However, SSRIs show activation syndrome in 54% of ASD youth requiring discontinuation in 35.4% of cases.

Practical Strategies and Treatment

Medication Considerations

Antipsychotic Treatment:

  • Risperidone and Aripiprazole have FDA-specific indication for irritability in ASD children
  • 5-HT2A antagonism preferred based on serotonergic alterations evidence
  • Careful monitoring for behavioral activation required

Mood Stabilizer Treatment:

  • Lithium first-choice with positive family history for bipolar illness
  • Valproate shows 70% efficacy for hyperactivity, impulsivity, aggression
  • Anticonvulsants useful when Epilepsy co-occurs

Critical Warning: Antidepressants can destabilize mood in bipolar ASD, causing (hypo)manic switches and mixed symptoms.

Non-Pharmacological Interventions

Trauma-Informed Care: Given 94% abuse rates in AS populations, trauma-focused Assessment and treatment essential.

Family Psychoeducation: Addressing ASD as genetic-epigenetic condition, not caused by parenting. Many families were historically blamed.

Environmental Accommodation: For “pseudopsychosis” episodes, environmental modification may be more effective than antipsychotics.

Critical Warnings

Catatonia Risk

Identified in 12-17% of ASD clinical samples. Antipsychotics may precipitate or worsen catatonia in ASD-BD patients. Electroconvulsive therapy (ECT) is most persistently successful treatment.

Medication Response Variability

ASD populations have highly individualized drug responses requiring “tailor” technique:

  • Lower starting doses than typical
  • Slower titration pace
  • Frequent Assessment, especially early in treatment
  • Monitor for behavioral activation

Diagnostic Overshadowing in Low-Functioning Asd

Restricted behavioral repertoire in lower-functioning autism with intellectual disability makes psychiatric symptom differentiation difficult. Longer observation periods from multiple informants necessary.